Astrazeneca Pharma IND LT

Astrazeneca Pharma Ind Lt (ASTRAZEN) is a small-cap Healthcare company valued at ₹14,926 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Astrazeneca Pharma Ind Lt last traded at ₹5,932, modestly down 0.08% on the day.

Recent developments

2026-08-10: The company reported a 32% drop in Q1 net profit to ₹38 crore, despite a 30% year-over-year revenue growth. This marks a significant decline in profitability compared to the same period last year.

Financial performance

The company's business is improving, with annual revenue rising 32.6% and net profit growing 61.7% year-over-year. However, the latest quarter saw net profit fall 32.3% compared to the same quarter a year earlier, despite revenue increasing 29.8%. The net profit margin improved by 1.5 percentage points to 8.2%, while return on equity remained at 21.5%.

Valuation multiples

The stock trades at 79.1 times earnings, a premium to the Healthcare median of 32.0, 19.65 times book value. It yields 0.5%.

Things to watch

The stock is 38.8% below its 52-week high, indicating a substantial pullback from recent peak levels. Net profit in the latest quarter fell 32.3% compared to the same quarter a year earlier, despite revenue growth. The company's profit growth has slowed in the most recent quarter, which could signal underlying challenges in maintaining profitability.

Where it stands

The company has delivered strong annual revenue and profit growth, but the latest quarter shows a sharp decline in net profit. The stock is significantly below its 52-week high, and the recent drop in quarterly profits raises concerns about sustaining growth. The most significant movement is the 32.3% fall in net profit for the latest quarter.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.